Enovix (ENVX) is back in focus as traders build positions ahead of the May 6 earnings report, with call option activity increasing and attention on its 100% silicon anode batteries for AI wearables and smartphones.

At a share price of $6.77, Enovix has seen a 1 month share price return of 33.79% while the year to date share price return remains at a 14.20% decline, and the 1 year total shareholder return sits at 6.61%. This suggests that recent momentum is building off a weaker longer term base as traders react to the upcoming earnings report and interest in its silicon anode technology.

If you are watching how AI linked battery names are trading, it can also be useful to see what is happening across smaller AI focused companies using the 66 profitable AI stocks that aren't just burning cash

With the stock at $6.77, trading at a large discount to the average analyst price target of $14.45 and an estimated 60% intrinsic discount, you have to ask: is this a genuine opportunity, or is the market already baking in all the future growth?

Most Popular Narrative: 53.1% Undervalued

Enovix's most followed narrative pegs fair value at $14.45 per share compared to the last close at $6.77, so the story hinges on execution catching up to expectations.

Completion of the site acceptance testing for the high-volume manufacturing line in Malaysia is set to boost production capacity and support significant revenue growth, with a focus on readiness for smartphone mass production in the fourth quarter of 2025. Successful shipment of early engineering smartphone battery samples and positive safety test results indicate future revenue increase potential, pending successful customer qualification for anticipated commercial smartphone launches in 2025.

Curious what earnings path could justify that kind of gap between price and fair value? The narrative leans heavily on rapid revenue expansion, margin flip, and a premium future multiple. The exact assumptions may surprise you.

Result: Fair Value of $14.45 (UNDERVALUED)

However, this depends on smartphone qualification and high volume production going according to plan, and on heavy manufacturing spending not outpacing actual customer demand.

Another View: What The Sales Multiple Is Saying

Our DCF model points to a fair value of $16.76 per share, which would also frame Enovix as undervalued versus the current $6.77 price. That sits alongside the analyst target of $14.45 and raises a simple question for you: are both models being too optimistic about execution risk?

Next Steps

If this mix of excitement and uncertainty around Enovix resonates with you, now is a good time to test the numbers yourself, pressure test the key assumptions, and see how they stack up against the 2 key rewards

Looking for more investment ideas?

If Enovix is on your radar, do not stop there. Rounding out your watchlist with a few focused stock ideas can sharpen your next move.

• Target dependable income with quality names that currently screen as 13 dividend fortresses and see which ones might fit your cash flow goals.
• Hunt for mispriced quality by scanning 51 high quality undervalued stocks and compare how their fundamentals stack up against the expectations baked into current prices.
• Prioritize resilience first by filtering for 70 resilient stocks with low risk scores and see which companies score well on stability before you commit fresh capital.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.